BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17507367)

  • 1. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.
    Helske S; Laine M; Kupari M; Lommi J; Turto H; Nurmi L; Tikkanen I; Werkkala K; Lindstedt KA; Kovanen PT
    Eur Heart J; 2007 Aug; 28(15):1894-903. PubMed ID: 17507367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.
    Helske S; Syväranta S; Kupari M; Lappalainen J; Laine M; Lommi J; Turto H; Mäyränpää M; Werkkala K; Kovanen PT; Lindstedt KA
    Eur Heart J; 2006 Jun; 27(12):1495-504. PubMed ID: 16401677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
    Peltonen TO; Taskinen P; Soini Y; Rysä J; Ronkainen J; Ohtonen P; Satta J; Juvonen T; Ruskoaho H; Leskinen H
    Circulation; 2007 Sep; 116(11):1283-9. PubMed ID: 17709640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis.
    Syväranta S; Helske S; Laine M; Lappalainen J; Kupari M; Mäyränpää MI; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1220-7. PubMed ID: 20299690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of local angiotensin II-producing systems in stenotic aortic valves.
    Helske S; Lindstedt KA; Laine M; Mäyränpää M; Werkkala K; Lommi J; Turto H; Kupari M; Kovanen PT
    J Am Coll Cardiol; 2004 Nov; 44(9):1859-66. PubMed ID: 15519020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves.
    Peltonen T; Ohtonen P; Näpänkangas J; Ohukainen P; Ruskoaho H; Taskinen P
    J Heart Valve Dis; 2011 Sep; 20(5):545-51. PubMed ID: 22066359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves.
    Pohjolainen V; Mustonen E; Taskinen P; Näpänkangas J; Leskinen H; Ohukainen P; Peltonen T; Aro J; Juvonen T; Satta J; Ruskoaho H; Rysä J
    Atherosclerosis; 2012 Jan; 220(1):66-71. PubMed ID: 22035575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.
    Lommi JI; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Kupari M; Helske S
    Atherosclerosis; 2011 Dec; 219(2):538-44. PubMed ID: 21917259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
    Côté N; Couture C; Pibarot P; Després JP; Mathieu P
    Eur J Clin Invest; 2011 Nov; 41(11):1172-9. PubMed ID: 21988540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic activation of valvular endothelial cells in aortic valve stenosis.
    Chalajour F; Treede H; Ebrahimnejad A; Lauke H; Reichenspurner H; Ergun S
    Exp Cell Res; 2004 Aug; 298(2):455-64. PubMed ID: 15265693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
    Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
    J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease.
    Kapusta P; Wypasek E; Natorska J; Grudzien G; Sobczyk D; Sadowski J; Undas A
    Thromb Haemost; 2012 Dec; 108(6):1172-9. PubMed ID: 23052999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
    Peltonen T; Näpänkangas J; Ohtonen P; Aro J; Peltonen J; Soini Y; Juvonen T; Satta J; Ruskoaho H; Taskinen P
    Atherosclerosis; 2011 May; 216(1):35-43. PubMed ID: 21316680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.